EUVIMEDEUVIMED entdecken
Crossref

Dual‑payload antibody‑drug conjugates in triple‑negative breast cancer: Preclinical advances and future perspectives (Review)

Rahmah Syala, Esraa Younus, Mohammed Abed, Fawaz Alassaf

World Academy of Sciences Journal · 30.10.2026 · 8 (6) · 1-10

DOI: 10.3892/wasj.2026.521 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Academy of Sciences Journal, online erschienen am 30.10.2026. Verfasst von Rahmah Syala und 3 weiteren Autor:innen. Die Arbeit nennt 89 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Syala, R., Younus, E., Abed, M., & Alassaf, F. (2026). Dual‑payload antibody‑drug conjugates in triple‑negative breast cancer: Preclinical advances and future perspectives (Review). World Academy of Sciences Journal, 8(6), 1-10. https://doi.org/10.3892/wasj.2026.521

Vancouver

Syala R, Younus E, Abed M, Alassaf F. Dual‑payload antibody‑drug conjugates in triple‑negative breast cancer: Preclinical advances and future perspectives (Review). World Academy of Sciences Journal. 2026;8(6):1-10. doi:10.3892/wasj.2026.521

BibTeX
@article{Syala2026,
  author = {Syala, Rahmah and Younus, Esraa and Abed, Mohammed and Alassaf, Fawaz},
  title = {Dual‑payload antibody‑drug conjugates in triple‑negative breast cancer: Preclinical advances and future perspectives (Review)},
  journal = {World Academy of Sciences Journal},
  year = {2026},
  volume = {8},
  number = {6},
  pages = {1--10},
  doi = {10.3892/wasj.2026.521}
}
Kostenlos starten →